tirzepatide elevated liver enzymes Eli Lilly's Zepbound improved scarring in mid-stage MASH study Effect of tirzepatide versus insulin

Park, S., Zhang, T., Wu, X

Desde una perspectiva clnica y basada en los ensayos de fase II y los datos preliminares, la eficacia de la retatrutida es superior a cualquier agente farmacolgico previo, con reducciones de peso corporal que oscilan entre el 25% y el 30% en un periodo de 48 semanas

Among individual GLP-1 RAs, exenatide exhibited the longest median time to onset at 45 days (IQR = 11213 days), while dulaglutide had the shortest at 7 days (IQR = 29 days), liraglutide at 16 days (IQR = 5.561 days), semaglutide at 12 days (IQR = 445.5 days), and tirzepatide at 10 days (IQR = 235.5 days)

It is important to note that semaglutide should be injected on the same day each week for optimal results